Expanded response letter to "Hemodialysis dose and frequency should be considered in the subgroup analysis".
作者信息
Lin Li-Chun, Wang Chung-An, Wu Vin-Cent
机构信息
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
College of Medicine, Taipei Medical University, Taipei, Taiwan.
出版信息
Cardiovasc Diabetol. 2024 Nov 19;23(1):417. doi: 10.1186/s12933-024-02483-w.
Abstract
摘要
相似文献
1
Expanded response letter to "Hemodialysis dose and frequency should be considered in the subgroup analysis".致《亚组分析中应考虑血液透析剂量和频率》的扩展回复信
Cardiovasc Diabetol. 2024 Nov 19;23(1):417. doi: 10.1186/s12933-024-02483-w.
2
Hemodialysis dose and frequency should be considered in subgroup analysis.在亚组分析中应考虑血液透析剂量和频率。
Cardiovasc Diabetol. 2024 Nov 19;23(1):416. doi: 10.1186/s12933-024-02482-x.
3
Evaluation of the Cost of a High-Dose Intravenous Iron Protocol in a Regional Hemodialysis Program: Research Letter.区域血液透析项目中高剂量静脉铁方案的成本评估：研究信
Can J Kidney Health Dis. 2021 Dec 8;8:20543581211063984. doi: 10.1177/20543581211063984. eCollection 2021.
4
Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.在成年和老年血液透析患者中，对标准单剂量无佐剂的 2009 年大流行性 H1N1 流感病毒 A 疫苗的免疫反应不佳。
Vaccine. 2012 Jul 13;30(33):5009-18. doi: 10.1016/j.vaccine.2012.05.016. Epub 2012 May 30.
5
Association of Dose and Frequency on the Survival of Patients on Maintenance of Hemodialysis in China: A Kaplan-Meier and Cox-Proportional Hazard Model Analysis.中国维持性血液透析患者生存的剂量和频率相关性：一项 Kaplan-Meier 和 Cox 比例风险模型分析。
Med Sci Monit. 2018 Jul 31;24:5329-5337. doi: 10.12659/MSM.909404.
6
Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis.在未经治疗的患者中，雷珠单抗治疗 nAMD 的基线特征和治疗反应预测：RACER 亚组分析。
BMC Ophthalmol. 2023 Jan 27;23(1):39. doi: 10.1186/s12886-023-02780-0.
7
8
Expanded home hemodialysis: case reports.扩展家庭血液透析：病例报告。
Int Urol Nephrol. 2020 May;52(5):977-980. doi: 10.1007/s11255-020-02455-5. Epub 2020 Apr 15.
9
Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis.
J Med Virol. 2009 Jul;81(7):1220-31. doi: 10.1002/jmv.21521.
10
Effects of Expanded Hemodialysis with Medium Cut-Off Membranes on Maintenance Hemodialysis Patients: A Review.采用中截留量膜进行延长血液透析对维持性血液透析患者的影响：一项综述
Membranes (Basel). 2022 Feb 23;12(3):253. doi: 10.3390/membranes12030253.
引用本文的文献
1
Potential benefits of GLP-1 receptor agonist in dialysis patients with type 2 diabetes: the need for comprehensive pharmacokinetic and hemodialysis analyses.胰高血糖素样肽-1受体激动剂对2型糖尿病透析患者的潜在益处：全面药代动力学和血液透析分析的必要性。
Cardiovasc Diabetol. 2025 Mar 8;24(1):110. doi: 10.1186/s12933-024-02543-1.
本文引用的文献
1
Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis.探讨开始透析时患有 T2DM 的患者使用 SGLT-2 抑制剂的死亡率和心血管结局：一项全球健康联合会分析。
Cardiovasc Diabetol. 2024 Sep 3;23(1):327. doi: 10.1186/s12933-024-02424-7.
Zotero 插件